ICT provider Fujitsu has partnered with Salesforce Japan, a customer relations management service company, to develop new digital solutions for the insurance sector.
WHAT IT'S ABOUT
According to a press statement, the two companies aim to support insurance companies in their development of optimised insurance products based on medical and health data.
To do this, Fujitsu will develop a system...
Tohoku University's Tohoku Medical Megabank Organization, pharmaceutical firms Daiichi Sankyo and Takeda Pharmaceutical Co., and medical IT company MICIN have started a collaborative research project to track long-term lifestyle habits to drive the creation of new drugs.
According to a press statement, the organisations will loan wearable tracking devices to about 2,000 participants. Over a year...
ICT provider Fujitsu has partnered with research institute Riken in Japan to jointly work on new-generation IT drug discovery technology to accelerate digital transformation in drug discovery.
According to a press statement, the organisations will utilise the supercomputer Fugaku, which they have developed together in the past decade, along with simulation AI technologies. Through these...
Japan's Ministry of Health, Labour and Welfare has awarded the Japanese medtech startup CureApp a medical device regulatory approval for its digital therapeutic app for hypertension.
WHAT IT DOES
CureApp's latest DTx app assists patients in maintaining lifestyle improvements as part of their treatment for hypertension. It automatically delivers personalised guidance to users, including advice on...
Fujitsu has teamed up with Southern Tohoku General Hospital in Fukushima, Japan for a joint research project to come up with an AI solution that detects pancreatic cancer from CT scans at an early stage.
According to a press release, the project will use Fujitsu's AI tech, which has been trained with over 300 anonymised CT images of pancreatic cancer patients at Southern Tohoku General Hospital,...
Japanese medtech firm AI Medical Service has raised 8 billion yen ($70 million) in a Series C funding round led by Masayoshi Son’s SoftBank Vision Fund 2, along with other existing investors Globis Capital Partners, World Innovation Lab, and Incubate Fund.
AIM develops an AI decision support tool for endoscopists who are screening for abnormalities, including signs of gastrointestinal cancer, in...
Taiwanese mobile health developer iXensor has obtained an undisclosed strategic investment from Rohto Pharmaceutical Co. to broaden the access to its core technology that transforms smartphones into IVD devices.
On Wednesday, the company announced that the publicly-listed Japanese pharma company became its latest partner and shareholder who will help expand its business globally and promote its...
Japanese medtech startup Ubie has launched its AI symptom checker in the United States.
The web-based Ubie AI Symptom Checker generates relevant questions about a user's symptoms from around 3,500 question data types based on its database of 50,000 medical papers.
After answering about 20 questions, users can discover related diseases and more detailed information about their possible conditions...
Fujifilm Corporation has developed AI technology that can predict whether patients with mild cognitive impairment will progress to Alzheimer's disease within two years.
According to a press statement, the AI Technology for AD Progression Prediction has been found to have high generalisability, predicting patients who would progress to AD with high accuracy, even for subjects from different...
Hong Seng's eMedAsia, CLEA partner to provide virtual COVID-19 screening for international travel
Malaysian digital health platform eMedAsia has started offering online COVID-19 testing services through its partnership with CLEA Technology.
Its partner provides virtual COVID-19 RTK and PCR screening services via the CLEADOC mobile app. It serves travellers who are seeking COVID-19 tests as a pre-...
